Measuring Impact in Patient-Centered Drug Development Conference

The work of early adopters of patient engagement has extended to the development of effectiveness and impact measures of patient involvement during the medical product lifecycle. As theoretical concepts have been translated to practical applications, common metrics have emerged for measuring process implementation as well as quality and impact of engagement. This session will identify commonly used metrics and present case studies of specific applications. Difficult to measure areas will be examined with discussion of suitable metrics that can be developed to assess progress and impact of patient centered efforts.